Ticker
DNTHCompany Name
DIANTHUS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -100.36M | -2067.55% | $ 4.85M |
3/31/2025 | $ -90.97M | -1394.33% | $ 6.52M |
12/31/2024 | $ -78.28M | -1255.57% | $ 6.24M |
9/30/2024 | $ -62.67M | -1167.98% | $ 5.37M |
6/30/2024 | $ -26.18M | -635.79% | $ 4.12M |
3/31/2024 | $ -17.61M | -780.84% | $ 2.25M |
12/31/2023 | $ -36.97M | -1308.24% | $ 2.83M |
9/30/2023 | $ -41.8M | -4523.27% | $ 924K |
6/30/2023 | $ -70.96M | 0% | $ 0 |
3/31/2023 | $ -81.97M | 0% | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for DIANTHUS THERAPEUTICS INC is calculated as follows: FCF [ $ -66.26M ] / Revenues [ $ 0 ]
(=) FCF % [ 0% ]
Minimum
Sep 30, 2023
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.85% |
median | 7.37% |
std | 19.48% |